Em (Embody) review

Embody advertises sermorelin and NAD⁺ injections at $49 for the first month, then $99 a month under a Pre-Black Friday offer. Glutathione has a separate $99 monthly promotion. The practical catch is the contract: subscription begins at payment, cancellation needs 72 hours’ notice, and paid terms are nonrefundable. A medical-disqualification refund deducts services already provided. Four named pharmacy partners are useful disclosure, but the assigned dispenser and complete order still need confirmation. The NAD⁺ anti-aging claims have no controlled human outcome support.

Embody is operated by Modern Metabolic Medicine, Inc., a Delaware corporation, trading as Em. Clinical decisions are made by independent providers through the OpenLoop Health network. Its main site promotes compounded GLP-1 treatment; separate program pages cover sermorelin, NAD⁺ and glutathione. Sermorelin and NAD⁺ injections are advertised; the NAD⁺ page also mentions nasal spray without establishing a route-specific price or order. Personalized amount ranges do not establish dispensed strength, quantity or supply. It displays a LegitScript seal and names Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx, without a product-specific assignment. Terms restrict service to available US states and adults; a state list must be requested rather than assuming universal coverage.

Each program has its own promotional page. The sermorelin page advertises an online evaluation, shipping from a licensed US pharmacy and no insurance or bloodwork required. For a growth-hormone-axis peptide that is the sentence to stop on: an IGF-1 baseline is the obvious thing to want before starting a secretagogue, and here its absence is sold as a feature. An OpenLoop Health clinician decides whether treatment is appropriate after payment. Telemedicine, prescription and free shipping are advertised as included; no extra membership fee does not mean there is no subscription. NAD⁺ and glutathione arrival claims of one to two days should be read alongside separate approval and shipping steps, not as a guaranteed time from signup. The assigned pharmacy and state eligibility need confirmation. Privacy and consent documents describe platform and provider data flows; they do not independently establish security compliance.

Sermorelin and NAD⁺ advertise $49 for the first month and $99 a month afterwards under the Pre-Black Friday promotion, described as $100 off initially and $50 off subsequent months. The NAD⁺ page mentions nasal spray without confirming that route’s price. Glutathione separately advertises $99 monthly, $100 monthly savings and a no-increase promise; do not apply the $49 introduction to it. None of these headlines establishes the exact selected first debit, strength, quantity, supply or prepaid-plan terms. The main GLP-1 site advertises $69 monthly and GLP-1/GIP $119 with an instant-discount qualifier; standing renewal prices are unconfirmed. Under the August 25 refund policy, subscription starts at payment and all purchased terms, including unused months of bundles, are final and nonrefundable, without monthly prorating. Cancellation through the account or support must arrive 72 hours before the next billing date; later requests allow another nonrefundable charge and take effect the following cycle. Medical disqualification refunds only the unused portion after deducting consultations, reviews, prescriptions or labs already provided. Damaged or incorrect medication qualifies for replacement only.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Embody names four partner pharmacies — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx — with addresses, which genuinely does let you check who dispenses your medication, and compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are, so that matters. The claims are where this needs contradicting directly. The NAD⁺ lander is headed "start aging backwards", calls NAD⁺ the fountain-of-youth peptide, tells readers it is scientifically proven to help them feel younger, sharper and more alive, and lists revitalizing cellular DNA and rejuvenating youthful skin among its benefits. There are no controlled human outcome trials behind any of that for injected NAD⁺; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly. The NAD⁺ forms with human data are the oral precursors NR and NMN, and what those trials demonstrate is a raised blood NAD⁺ level — a biomarker, not an outcome. The sermorelin page is more careful, framing benefits as "may support" and stating that sermorelin is not intended for anti-aging, bodybuilding or athletic performance, and its mechanism description is broadly accurate: sermorelin is a GHRH analog that stimulates the pituitary rather than replacing hormone. But the long-term human outcome data remains thin, and no controlled trial demonstrates the weight, muscle, skin, bone or sleep results the page lists. Glutathione has essentially no controlled human outcome evidence. Individual results vary.